Vitamin d, immune tolerance, and prevention of type 1 diabetes

Current Diabetes Reports

Volumn 12, Issue 6, 2012, Pages 635-642

  Badenhoop, Klaus ^a   Kahles, Heinrich ^a   Penna Martinez, Marissa ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Antigen expression; Immune tolerance; Recognition and processing; Residual cell secretion; T helper lymphocytes; T regulatory; Type 1 diabetes prevention; Vitamin D

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; CD3 ANTIBODY; COLECALCIFEROL; CYCLOSPORIN A; GLUCOSE; INSULIN; TX 527; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; ANTIDIABETIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CYP27B1 GENE; CYP2R1 GENE; DHCR7 GENE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MEGADOSE; GC GENE; GENE; GENE CONTROL; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEALTH STATUS; HUMAN; IMMUNE DYSREGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SENSITIVITY; INSULITIS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PERSONALIZED MEDICINE; PREGNANCY OUTCOME; REVIEW; RISK BENEFIT ANALYSIS; SUN EXPOSURE; TREATMENT OUTCOME; ULTRAVIOLET IRRADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADAPTIVE IMMUNITY; DIABETES MELLITUS, TYPE 1; DIETARY SUPPLEMENTS; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; MALE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84870706035     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-012-0322-3     Document Type: Review

References (68)

1. Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes. 2011;60(5):1624-31. Both vitamin D deficiency and four genetic polymorphisms are significantly associated with type 1 diabetes.
2. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab. 2005;16(6):261-6.
3. Bikle DD. Vitamin D, and the skin: Physiology and pathophysiology. Rev Endocr Metab Disord. 2012;13(1):3-19.
4. Blomberg JM, Bjerrum PJ, Jessen TE, et al. Vitamin D is positively associated with sperm motility and increases intracellular calcium in human spermatozoa. Hum Reprod. 2011;26(6):1307-17.
5. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S-6S.
6. Holick MF. Vitamin D, deficiency. N Engl J Med. 2007;357 (3):266-81.
7. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30.
8. Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab. 2012;97(4):1146-52.
9. Pozzilli P, Manfrini S, Crino A, et al. Low levels of 25- hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2005;37 (11):680-3.
10. Littorin B, Blom P, Scholin A, et al. Lower levels of plasma 25- hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia. 2006;49(12):2847-52.
11. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832-8.
12. Staples JA, Ponsonby AL, Lim LL, McMichael AJ. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ Health Perspect. 2003;111(4):518-23.
13. Hypponen E. Preventing vitamin D deficiency in pregnancy: importance for the mother and child. Ann Nutr Metab. 2011;59(1):28-31.
14. Clydesdale GJ, Dandie GW, Muller HK. Ultraviolet light induced injury: immunological and inflammatory effects. Immunol Cell Biol. 2001;79(6):547-68.
15. Elliott JC, Lucas RM, Clements MS, Bambrick HJ. Population density determines the direction of the association between ambient ultraviolet radiation and type 1 diabetes incidence. Pediatr Diabetes. 2010;11(6):394-402.
16. Sloka S, Grant M, Newhook LA. Time series analysis of ultraviolet B radiation and type 1 diabetes in Newfoundland. Pediatr Diabetes. 2008;9(2):81-6.
17. Newhook LA, Grant M, Sloka S, et al. Very high and increasing incidence of type 1 diabetes mellitus in Newfoundland and Labrador, Canada. Pediatr Diabetes. 2008;9(3 Pt 2):62-8.
18. Kaur H, Donaghue KC, Chan AK, et al. Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. Diabetes Care. 2011;34(6):1400-2.
19. Shea MK, Benjamin EJ, Dupuis J, et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr. 2009;63(4):458-64.
20. Orton SM, Morris AP, Herrera BM, et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr. 2008;88(2):441-7.
21. Hunter D, de Lange M, Snieder H, et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res. 2001;16(2):371-8.
22. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180-8. This first genome-wide association study proves that four genes regulate vitamin D levels.
23. Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19(13):2739-45.
24. Bailey R, Cooper JD, Zeitels L, et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes. 2007;56(10):2616-21.
25. Lopez ER, Zwermann O, Segni M, et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol. 2004;151(2):193-7.
26. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476(7359):214-9.
27. Sundqvist E, Baarnhielm M, Alfredsson L, Hillert J, Olsson T, Kockum I. Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet. 2010;18(12):1349-52.
28. Wu S, Ren S, Nguyen L, Adams JS, Hewison M. Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology. 2007;148(7):3410-8.
29. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726-76.
30. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf). 2012;76(3):315-25.
31. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010;20 (10):1352-60. This is the first paper describing genome-wide vitamin D effects om liganded VDR at vitamin D regulated gene loci in lymphoblast cells.
32. Heikkinen S, Vaisanen S, Pehkonen P, Seuter S, Benes V, Carlberg C. Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 2011;39(21):9181-93. This paper addresses vitamin D effects with an approach similar to that in [7] but treats its monocytic cell lines differently, arriving at some different gene transription profiles. Taken together, these two papers illustrate the pleiotropic actions of vitamin D for the first time on the genomic level.
33. NguyenM, d'Alesio A, Pascussi JM, et al.Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25- dihydroxyvitamin D3. J Bone Miner Res. 2006;21(6):886-94.
34. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol. 2011;7(6):337-45. This review explains the complex regulation of innate immunityby vitamin D.
35. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770-3.
36. Liu NQ, Hewison M. Vitamin D, the placenta and pregnancy. Arch Biochem Biophys. 2012;523(1):37-47.
37. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 2010;11(4):344-9. Vitamin D is required for T lymphocyte signaling, thus finetuning the adaptive immunity, avoiding an overreaction.
38. Baeke F, Korf H, Overbergh L, et al. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol. 2010;121(1-2):221-7.
39. Joshi S, Pantalena LC, Liu XK, et al. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol. 2011;31(17):3653- 69.
40. Lisse TS, Hewison M. Vitamin D: a new player in the world of mTOR signaling. Cell Cycle. 2011;10(12):1888-9. A new mechanism for vitamin D effects in the antiproliferative action and on immune cells is reviewed, based on [41].
41. Lisse TS, Liu T, Irmler M, et al. Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling. FASEB J. 2011;25 (3):937-47.
42. Sebastiani G, Grieco FA, Spagnuolo I, Galleri L, Cataldo D, Dotta F. Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity. Diabetes Metab Res Rev. 2011;27(8):862-6.
43. Du C, Liu C, Kang J, et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol. 2009;10(12):1252-9.
44. Witham MD, Dove FJ, Khan F, Lang CC, Belch JJ, Struthers AD. Effects of Vitamin D supplementation on markers of vascular function after myocardial infarction-A randomised controlled trial. Int J Cardiol 2012.
45. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia. 1994;37(6):552-8. This landmark paper demonstrated for the first time the ß-cell protective of vitamin D in the NOD mouse model.
46. Pedersen LB, Nashold FE, Spach KM, Hayes CE. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res. 2007;85(11):2480-90.
47. Chang JH, Cha HR, Lee DS, Seo KY, Kweon MN. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T (H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One. 2010;5(9):e12925.
48. Cantorna MT, Hayes CE, Deluca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr. 1998;128(1):68-72.
49. Cantorna MT, Hayes CE, Deluca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A. 1996;93 (15):7861-4.
50. Baeke F, Van Belle TL, Takiishi T et al. Low doses of anti-CD3, ciclosporin A and the vitamin D analogue, TX527, synergise to delay recurrence of autoimmune diabetes in an islet-transplanted NOD mouse model of diabetes. Diabetologia 2012.
51. Ghoreishi M, Bach P, Obst J, Komba M, Fleet JC, Dutz JP. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol. 2009;182(10):6071-8.
52. Prietl B, Pilz S, Wolf M, et al. Vitamin D supplementation and regulatory Tcells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J. 2010;12(3):136-9.
53. Yu S, Cantorna MT. Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. J Immunol. 2011;186(3):1384-90. The vitamin D deficiency and its effects on iNKT cells experienced in utero cannot be overcome by treatment of mice after birth. This illustrates the importance of pregnancyrelated imprinting of the vitamin D system.
54. Sorensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, Stene LC. Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes. 2012;61(1):175-8.
55. Fronczak CM, Baron AE, Chase HP, et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care. 2003;26(12):3237-42.
56. Simpson M, Brady H, Yin X, et al. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2011;54(11):2779-88.
57. Bizzarri C, Pitocco D, Napoli N, et al. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care. 2010;33(9):1962-3.
58. Chun RF, Peercy BE, Adams JS, Hewison M. Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25- dihydroxyvitamin D: analysis by mathematical modeling. PLoS One. 2012;7(1):e30773. An algorithm is presented for calculating the free, unbound fraction of 25D in serum or plasma.
59. Burgess MA, Forrest JM. Congenital rubella and diabetes mellitus. Diabetologia. 2009;52(2):369-70.
60. Robinson CJ, Wagner CL, Hollis BW, Baatz JE, Johnson DD. Maternal vitamin D and fetal growth in early-onset severe preeclampsia. Am J Obstet Gynecol. 2011;204(6):556-4.
61. Hollis BW, Wagner CL. Vitamin D and Pregnancy: Skeletal Effects, Nonskeletal Effects, and Birth Outcomes. Calcif Tissue Int 2012.
62. Kallas M, Green F, Hewison M, White C, Kline G. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab. 2010;95(7):3111-7. Hypercalcemia may be a rare adverse event of vitamin D treatment, hereby unmasking an underlying neoplastic or granulomatous condition.
63. Schlingmann KP, Kaufmann M, Weber S, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011;365(5):410-21. Polymorphisms or mutations of the CYP24A1 gene encoding a vitamin D inactivating enzyme may be the cause of idiopathic hypercalcemia, potentially aggravated by vitamin D treatment.
64. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820-5.
65. Bourlon PM, Faure-Dussert A, Billaudel B. The de novo synthesis of numerous proteins is decreased during vitamin D3 deficiency and is gradually restored by 1, 25-dihydroxyvitamin D3 repletion in the islets of langerhans of rats. J Endocrinol. 1999;162(1):101- 9.
66. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209 (4458):823-5.
67. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, Deluca HF. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology. 1983;113(4):1511-8.
68. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003;17(3):509-11.